Glycan’s in Vaccine Development

Glycan’s are at the centre of many disorders and diseases igniting the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycan’s are intricately involved. Determining the entire capacity and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Biomarkers in drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Glycan’s in Vaccine Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in